'Atypical hyperplasia' presentation slideshows

Gynaecological pathology

September 2019 Bristol. Gynaecological pathology.

537 views • 46 slides

Study of Tamoxifen and Raloxifene STAR

Larry Wickerham, MD NSABP STAR Project Officer. Study of Tamoxifen and Raloxifene STAR. 50. 40. 30. 20. 10. 0. NSABP P1 Study. Invasive Breast Cancer. Noninvasive Breast Cancer. 50. # Events Placebo 250 Tamoxifen 145. # Events Placebo 93 Tamoxifen 60. 40. 30.

507 views • 24 slides

PCOS

280 views • 23 slides

Endometrial Cancer

Endometrial Cancer. ASSOCIATE PROFESSOR Iolanda Blidaru MD, PhD. Incidence corpus 32,000 ovary 21,000 cervix 13,500 other 4500. Mortality 4400 13,000 5600 1000. ACS Statistics, 1992.

313 views • 21 slides

ENDOMETRIAL HYPERPLASIA INCIDENCE

ENDOMETRIAL HYPERPLASIA INCIDENCE. Arian Alikaj, Rubena Moisiu. Endometrial hyperplasia incidence.

833 views • 10 slides

Endometrial hyperplasia

Endometrial hyperplasia. 44 years old woman, G 2 L 2 History of menorrhagia in last 2years with regular cycle DX : Neg. Lab data ; Hb: 10 coagulation test: NL sonography: endometrial thickness,8mm TX : FD&C Pathology report: Simple cystic hyperplasia of endometrium.

637 views • 7 slides